Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Vascular Malformations 1Uterine Cervical Dysplasia 1Lymphoma, T-Cell, Cutaneous 1Hemangioma, Capillary 1Hemangioma 1

Interventions

Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4fludarabine phosphate 3Cytarabine 3Whole-Body Irradiation 2Vorinostat 2Tacrolimus 2Radiotherapy 2Pentetic Acid 2Mycophenolic Acid 2Methotrexate 2sargramostim 1pembrolizumab 1fludarabine 1ethanolamine oleate 1durvalumab 1denileukin diftitox 1Vincristine 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Triamcinolone Acetonide 1Transplantation 1Thiotepa 1Therapeutics 1Surveys and Questionnaires 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, T-Cell, Cutaneous × Ointments × Clear all
NCT01843998 2015-06-04

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Medical College of Wisconsin

Phase 2 Withdrawn
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡